Stocks IOT

Samsara Consensus Price Target Increased by 19.13% to $54.20

The average one-year price target for Samsara (NYSE:IOT) has been revised to $54.20 / share. This is an increase of 19.13% from the prior estimate of $45.50 dated August 25, 2026. These figures represent aggregate analyst targets and do not constitute a recommendation by Fintel.

The price target is an average of many targets provided by analysts. The latest targets range from a low of $46.46 to a high of $63.00 / share. The average price target represents an increase of 26.32% from the latest reported closing price of $42.91 / share as of September 14, 2026. As of September 11, 2026, the current median target is $55.08, which increased from the prior median of $45.39. The target range widened, with the current target range width at $16.54 compared to the prior width of $14.12, representing a target range width change percent of +17.14%. The current mean-median gap is $0.88, and the absolute median change is $9.69.

Looking at the target history, the mean target was $54.20 on September 15, 2026, $45.50 on August 28, 2026, $44.76 on August 4, 2026, and $45.19 on June 30, 2026. The observed twelve-month high mean was $54.20 on September 15, 2026, and the observed twelve-month low mean was $44.51 on May 14, 2026. The consecutive target revision direction has increased for a count of 2 consecutive times. The target change since the 90-day baseline date of June 8, 2026, is +19.44%.

For context, Samsara's stock price changed by +6.74% over one week from a baseline close of $40.20 on September 4, 2026, and changed by +7.84% over one month from a baseline close of $39.79 on August 14, 2026. In its latest earnings report on September 3, 2026, Samsara reported actual EPS of 0.2, compared to the estimate of 0.1614, representing a surprise of +23.92%. Actual revenue was $508,437,000.00, compared to the estimate of $488,094,084.00, a surprise of +4.17%.

Recent analyst actions on September 4, 2026, include JP Morgan maintaining a Neutral rating, B of A Securities maintaining a Buy rating, BMO Capital maintaining an Outperform rating, and Morgan Stanley maintaining an Equal-Weight rating. As of September 1, 2026, the current recommendation total is 28, with 75.0% positive recommendations and 25.0% hold recommendations. This compares to a total of 28 recommendations as of August 1, 2026, which consisted of 78.6% positive and 21.4% hold recommendations.

Samsara belongs to the Application Software GICS sub-industry. Within this sub-industry, 24 companies are covered, with 14 raised, 6 lowered, and 4 unchanged. The sub-industry median revision percent is +0.43%, and the median implied change percent is +8.39%.

Peer companies in the connected operations and telematics space show varied target revisions and implied changes, with target revisions ranging from negative to positive territory.

Peer Comparison
Company name Target revision Implied change
Karooooo 0.00% +11.97%
Trimble -1.62% +39.82%
Camp4 Therapeutics +18.82% +142.40%

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

Fintel
Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford.
Check out our Unique Analysis of Insider Sentiment for Samsara Inc. Find out what the Options Markets think of Samsara Inc. See our take on Samsara Inc. Upcoming Earnings More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available